Galien Golden Jubilee Forum USA 2021

KEYNOTE
Oct. 28th, 2021
11:30AM – 12PM


In-person registrationLive broadcast registration

FULL PROGRAM

Ken Frazier
Executive Chairman of the Board of Directors
Merck & Co.

Kenneth C. Frazier has served as the Chairman of the Board, President and Chief Executive Officer of Merck & Co., Inc. since 2011. Under Ken’s leadership, Merck is delivering innovative lifesaving medicines and vaccines as well as long-term and sustainable value to its multiple stakeholders.  Ken has substantially increased Merck’s investment in research, including early research, while refocusing the organization on the launch and growth of key products that provide benefit to society.  He has also led the formation of philanthropic and other initiatives that build on Merck’s 125-year plus legacy.

Ken joined the company in 1992 and has held positions of increasing responsibility including General Counsel and President.  Prior to joining Merck, Ken was a partner with the Philadelphia law firm of Drinker Biddle & Reath.  Ken’s contributions, especially in the legal, business and humanitarian fields, have been widely recognized. He sits on the boards of PhRMA, Weill Cornell Medicine, Exxon Mobil Corporation, Catalyst and Cornerstone Christian Academy in Philadelphia, PA.  He also is a member of the American Academy of Arts and Sciences, the American Philosophical Society, The Business Council, the Council of the American Law Institute, and the American Bar Association.  Additionally, Ken is co-chair of the Legal Services Corporation’s Leaders Council.

Ken received his bachelor’s degree from The Pennsylvania State University and holds a J.D. from Harvard Law School.


Michael Rosenblatt
Galien Forum Co-Chair:
Senior Partner, Flagship Pioneering,
Cambridge, MA

Dr. Michael Rosenblatt’s career has been in academia, pharma and biotech/venture. He is a physician-scientist, now serving as a Senior Partner at Flagship Pioneering in Cambridge, MA, a firm that originates new biotech companies. Previously, he was Merck’s Chief Medical Officer. He also served as Dean of Tufts University School of Medicine, and before that, Robert Ebert Professor of Molecular Medicine and George R. Minot Professor at Harvard Medical School. He was President of Beth Israel Deaconess Medical Center and Director of the Harvard-MIT Division of Health Sciences and Technology. He graduated summa cum laude from Columbia, and received his M.D. magna cum laude from Harvard. Internship, residency, and endocrinology training were all at the Massachusetts General Hospital.